ArticleFrontiers in oncology2026

A blood-biomarker based CTC-ALRI score predicts recurrence in hepatocellular carcinoma patients following curative resection.

Jinfeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.